NEUREN PHARMACEUTICALS LTD (NURPF:OTCMKTS)
$14.2772 0 (0%)
Analysed NEUREN PHARMACEUTICALS LTD (NURPF:OTCMKTS) News Sources
Neuren Pharmaceuticals Limited (ASX:NEU) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
12-01-2026
yahoo.com
3 Australian Growth Stocks To Watch In September 2026
29-09-2026
yahoo.com
Cochlear And 2 Australian Healthcare Stocks To Watch
01-10-2026
yahoo.com
Top 3 Australian Healthcare Stocks To Watch In October 2026
08-10-2026
yahoo.com
3 Australian Growth Stocks To Watch In October 2026
09-10-2026
yahoo.com
Neuren Pharmaceuticals Ltd (NURPF) (H1 2026) Earnings Call Highlights: Record Royalties, First ...
27-08-2026
yahoo.com
What is the current price of NEUREN PHARMACEUTICALS LTD (NURPF:OTCMKTS)?
The current price of NEUREN PHARMACEUTICALS LTD (NURPF:OTCMKTS) is $14.2772.
NEUREN PHARMACEUTICALS LTD (NURPF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of NEUREN PHARMACEUTICALS LTD (NURPF:OTCMKTS) since the previous trading day is $0.
NEUREN PHARMACEUTICALS LTD (NURPF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of NEUREN PHARMACEUTICALS LTD (NURPF:OTCMKTS) since the previous trading day is 0%.
What is the most recent average sentiment score for NEUREN PHARMACEUTICALS LTD (NURPF:OTCMKTS)?
The most recent average sentiment score for NEUREN PHARMACEUTICALS LTD (NURPF:OTCMKTS) is 87 out of 100.
What is the most recent average sentiment for NEUREN PHARMACEUTICALS LTD (NURPF:OTCMKTS)?
The most recent sentiment for NEUREN PHARMACEUTICALS LTD (NURPF:OTCMKTS) is .
SEC-8K** Filing Available For NEUREN PHARMACEUTICALS LTD (NURPF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.